alexa Extracts From The Branch Of Abeliophyllum Distichum Nakai Induces Cyclin D1 Proteasomal Degradation Through Threonine-286 Phosphorylation
ISSN: 2327-5162

Alternative & Integrative Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference and Exhibition on Traditional & Alternative Medicine
August 25-26, 2014 DoubleTree by Hilton Beijing, China

Gwang Hun Park, Jae Ho Park, Hun Ji Eo, Hun Min Song, Jeong Rak Lee, Man Hyo Lee and Jin Boo Jeong
Posters: Altern Integ Med
DOI: 10.4172/2327-5162.S1.008
A beliophyllum distichum Nakai ( A distichum ) has been reported to exert the inhibitory effect on angiotensin converting enzyme and aldose reductase. Recently, our group found that branch extracts from ethyl acetate fraction from branch of A. distichum (EAFAD-B) induces apoptosis through ATF3 activation in human colorectal cancer cells. However, anti- cancer reagents exert their activity through the regulation of various molecular targets. Therefore, the elucidation of potential mechanisms of EAFAD-B for anti-cancer activity may be necessary. To elucidate the potential mechanism of EAFAD-B for anti-cancer activity, we evaluated the regulation of cyclin D1 in human colorectal cancer cells. EAFAD-B decreased cellular accumulation of exogenously-induced cyclin D1 protein. However, cyclin D1 mRNA was not changed by EAFAD-B. Inhibition of proteasomal degradation by MG132 attenuated silymarin-mediated cyclin D1 downregulation and the half-life of cyclin D1 was decreased in the cells treated with EAFAD-B. In addition, EAFAD-B induced threonine-286 phosphorylation of cyclin D1 and EAFAD-B-mediated cyclin D1 proteasomal degradation was attenuated by a point mutation of threonine-286 to alanine. Inhibitions of both ERK1/2 by PD98059 and NF-κB by a selective inhibitor, BAY 11-7082 suppressed cyclin D1 downregulation by EAFAD-B. Conclusion: From these results, we suggest that EAFAD-B-mediated cyclin D1 downregulation may result from proteasomal degradation through its threonine-286 phosphorylation via ERK1/2-dependent NF-κB activation. The current study provides new mechanistic link between EAFAD-B and anti-cancer activity in human colorectal cancer cells.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version